Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Scientists discover a powerful new antivenom hidden in rattlesnake blood | ScienceDaily (opens in a new tab)

sciencedaily.com · 2026-09-08

Short answerEvidenceSource

Short answer

Mostly supported

Mostly supported.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 3 supported
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly supported

Every claim we could check holds up. Three of four claims match the study. This overall rating is based only on the claims we could check. One claim the study doesn't address.

  • 3 supported
  • 1 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4Not coveredThe study focused on conserved rattlesnake serum metalloproteinase inhibitors, and the researchers say the approach could help develop a new generation of antivenoms that are broader, safer, less expensive, and easier to manufacture.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the focus on conserved rattlesnake serum Fetuin-A-like metalloproteinase inhibitors and supports a speculative broader-antivenom development rationale. However, the specific asserted advantages of being safer, less expensive, and easier to manufacture are not established in the supplied abstract-level profile, and no human safety, cost, or manufacturing evidence is available at this depth.

1

Study evidence

Individual recombinant rattlesnake FETUA proteins were unable or only partially able to inhibit venom lethality in the in vivo survival assays.

“...unable or only partially able to inhibit venom lethality.”
2

Study evidence

FETUA proteins are well conserved among viper subfamilies.

“...rattlesnake FETUAs are able to inhibit the MPs and neutralize the lethality of several evolutionarily distant pit viper or true viper venoms.”
Claim 2 of 4SupportedResearchers discovered that combinations of toxin-blocking proteins naturally found in rattlesnake blood can powerfully neutralize venom from several dangerous snake species.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that rattlesnake serum-derived FETUA proteins, especially in specific combinations, neutralized rattlesnake venom lethality and that rattlesnake FETUAs inhibited metalloproteinases and neutralized lethality from several evolutionarily distant pit viper/true viper venoms. The story’s broad wording about “venom” should be read in light of its caveats that the work focused on metalloproteinases and lab/animal experiments; the abstract does not provide species lists or detailed potency for each venom.

1

Study evidence

Individual recombinant rattlesnake FETUA proteins were unable or only partially able to inhibit venom lethality in the in vivo survival assays.

“...unable or only partially able to inhibit venom lethality.”
2

Study evidence

FETUA proteins are well conserved among viper subfamilies.

“...rattlesnake FETUAs are able to inhibit the MPs and neutralize the lethality of several evolutionarily distant pit viper or true viper venoms.”
Claim 3 of 4SupportedIn laboratory tests, the protein mixtures were about 10 times more potent than a current commercial antivenom.View evidenceHide evidence

As statedabout 10 times more potent

Why this verdict

The paper profile states that specific FETUA protein combinations were reported to be approximately tenfold more potent than a commercial antivenom in in vivo lethality-protection potency comparisons. The story’s “laboratory tests” framing is consistent with experimental lab/animal assays, not human clinical testing.

1

Study evidence

Individual recombinant rattlesnake FETUA proteins were unable or only partially able to inhibit venom lethality in the in vivo survival assays.

“...unable or only partially able to inhibit venom lethality.”
Claim 4 of 4SupportedThe researchers reported that individual proteins could affect some venom effects, but none alone completely prevented death; combinations were needed for strong protection.View evidenceHide evidence

Why this verdict

The profile reports that certain individual FETUA proteins inhibited enzymatic or hemorrhagic activity, but individual proteins were unable or only partially able to inhibit venom lethality; specific combinations complemented one another and fully neutralized rattlesnake venom lethality. This matches the story’s claim that single proteins affected some venom effects but combinations were needed for strong protection.

1

Study evidence

Some individual recombinant rattlesnake FETUA proteins inhibit viper venom metalloproteinase enzymatic activity in substrate-based in vitro assays.

“We have investigated the abilities of a family of four rattlesnake metalloproteinase (MP) inhibitors ... to neutralize the enzymatic ... activities of viper venoms.”
2

Study evidence

Some individual rattlesnake FETUA proteins inhibit the hemorrhagic activity of viper venoms.

“...neutralize the enzymatic, hemorrhagic, and lethal activities of viper venoms.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • An interpretation-changing limitation is that the abstract does not specify whether lethality protection was tested only by venom-inhibitor preincubation/co-administration or also in post-exposure therapeutic models, which matters for real-world antivenom use after a bite.

    The story notes future-facing translation but does not mention the administration-timing uncertainty highlighted in the paper profile.

    From In vivo venom-challenge lethality protection assays; preincubation/co-administration; dose–response potency comparison v

7 things the story did carry across
  • The central experimental finding is that specific combinations of recombinant rattlesnake FETUA metalloproteinase inhibitors fully neutralized rattlesnake venom lethality and were about tenfold more potent than a commercial antivenom in the reported animal lethality assays.
  • The work included in vitro metalloproteinase enzymatic inhibition assays showing that individual FETUAs can inhibit some venom MP activity and that combinations broaden/strengthen inhibition.
  • The paper also reports hemorrhagic activity neutralization, with individual proteins affecting some venom activities and combinations improving neutralization breadth/strength.
  • The paper reports cross-venom breadth: rattlesnake FETUAs inhibited metalloproteinase activity and neutralized lethality from several evolutionarily distant pit viper and true viper venoms.
  • The paper includes an evolutionary/conservation analysis reporting that FETUA proteins are well conserved among viper subfamilies.
  • A key limitation is that the potency and protection evidence in the abstract-level profile comes from experimental laboratory and animal models, not human clinical treatment or commercial use.
  • The study is centered on metalloproteinases, one toxin family, so neutralizing all clinically relevant venom effects or other toxin families remains outside the demonstrated evidence summarized here.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

5

Evidence read

study summary

Lead result

in vivo animal

1Lead resultin vivo animalDetermine whether individual vs combinatorial FETUA inhibitors neutralize in vivo venom lethality and how their potency compares with commercial antivenom.In vivo venom-challenge lethality protection assays; preincubation/co-administration; dose–response potency comparison vs commercial antivenomExpand

In plain English

In vivo venom lethality (survival) experiments reported in the paper show that individual recombinant rattlesnake FETUA metalloproteinase inhibitors were unable or only partially able to prevent venom-induced death, whereas specific combinations of FETUA proteins fully neutralized rattlesnake venom lethality and were reported to be approximately 10-fold more potent than a commercial antivenom in these assays.

Key findings

  • Individual recombinant rattlesnake FETUA proteins were unable or only partially able to inhibit venom lethality in the in vivo survival assays.
  • Specific combinations of FETUA proteins complemented one another and were sufficient to fully neutralize rattlesnake venom lethality in the reported assays.
“...unable or only partially able to inhibit venom lethality.”
What this piece can’t prove
  • Unclear whether protection was assessed only with preincubation/co-administration or also in post-exposure therapeutic models.

2 further details could not be confirmed from the summary.

2in vitroTest whether individual rattlesnake serum-derived Fetuin-A–like metalloproteinase inhibitors (FETUAs) inhibit viper venom metalloproteinase activity and downstream hemorrhagic activity, and whether combinations improve neutralization breadth/strength.in vitro enzymatic inhibition assaysExpand

In plain English

In vitro substrate-based enzymatic assays show that among four recombinant rattlesnake Fetuin-A–derived metalloproteinase inhibitors (FETUAs), some individual proteins can inhibit viper venom metalloproteinase (MP) enzymatic activity, but individual inhibition is incomplete for functional neutralization; specific combinations of FETUAs display complementary activity and produce stronger/broader enzymatic inhibition than single agents.

Key findings

  • Some individual recombinant rattlesnake FETUA proteins inhibit viper venom metalloproteinase enzymatic activity in substrate-based in vitro assays.
  • Individual FETUA inhibitors were insufficient or only partially effective for functional neutralization, motivating combination testing.
“We have investigated the abilities of a family of four rattlesnake metalloproteinase (MP) inhibitors ... to neutralize the enzymatic ... activities of viper venoms.”
What this piece can’t prove
  • Findings reflect in vitro biochemical (substrate-based) assays; applicability to in vivo outcomes requires separate appraisal.

2 further details could not be confirmed from the summary.

3in vivo animalTest whether individual rattlesnake serum-derived Fetuin-A–like metalloproteinase inhibitors (FETUAs) inhibit viper venom metalloproteinase activity and downstream hemorrhagic activity, and whether combinations improve neutralization breadth/strength.venom hemorrhage model (localized hemorrhage assay); single vs combination inhibitor comparisonsExpand

In plain English

The paper reports testing of rattlesnake-derived Fetuin-A–like metalloproteinase inhibitors (FETUAs) for inhibition of viper venom hemorrhagic activity. The authors state that certain individual FETUA proteins can inhibit enzymatic or hemorrhagic activity of venoms, but that specific combinations of FETUA proteins complement one another and increase neutralization activity/breadth relative to single proteins.

Key findings

  • Some individual rattlesnake FETUA proteins inhibit the hemorrhagic activity of viper venoms.
  • Specific combinations of FETUA proteins complement one another and increase neutralization activity/breadth compared with single proteins.
“...neutralize the enzymatic, hemorrhagic, and lethal activities of viper venoms.”
What this piece can’t prove
  • The appraisal assumes an in vivo hemorrhage model as per the unit scope; the abstract does not detail whether hemorrhage measurements were performed in vivo, ex vivo, or by which specific metric.

2 further details could not be confirmed from the summary.

4in vivo animalAssess evolutionary conservation of FETUA inhibitors across viper subfamilies and whether rattlesnake FETUAs cross-neutralize diverse pit viper/true viper venoms’ MP activity and lethality.Multi-venom biochemical and in vivo neutralization panelExpand

In plain English

The paper reports that rattlesnake-derived FETUA metalloproteinase (MP) inhibitors are conserved across viper subfamilies and that rattlesnake FETUAs can inhibit MP enzymatic activity and neutralize lethality from several evolutionarily distant pit viper and true viper venoms, based on a multi-venom breadth test of biochemical MP inhibition and in vivo lethal challenge.

Key findings

  • FETUA proteins are well conserved among viper subfamilies.
  • Rattlesnake FETUA proteins inhibit metalloproteinase activity and can neutralize the lethality of several evolutionarily distant pit viper and true viper venoms.
“...rattlesnake FETUAs are able to inhibit the MPs and neutralize the lethality of several evolutionarily distant pit viper or true viper venoms.”
What this piece can’t prove
  • Unclear whether cross-neutralization required specific combinations of FETUAs or whether single FETUA proteins were sufficient for each tested venom.

1 further detail could not be confirmed from the summary.

5in silicoAssess evolutionary conservation of FETUA inhibitors across viper subfamilies and whether rattlesnake FETUAs cross-neutralize diverse pit viper/true viper venoms’ MP activity and lethality.sequence conservation analysisExpand

In plain English

The abstract reports a comparative sequence/phylogenetic analysis showing that Fetuin-A–derived FETUA metalloproteinase inhibitors are well conserved across viper subfamilies.

Key findings

  • FETUA proteins are reported to be well conserved among viper subfamilies.
“Moreover, we demonstrate that FETUA proteins are well conserved among viper subfamilies...”
What this piece can’t prove
  • Abstract does not provide details of the computational methods, sequence sampling, or quantitative conservation metrics.
  • Cannot assess robustness/reproducibility of the conservation analysis from abstract text alone (no sample sizes, accession lists, alignment/phylogeny parameters, or statistical measures reported).
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Nature's antivenom: Combinations of conserved rattlesnake serum metalloproteinase inhibitors block the lethal action of viper venoms.

Proceedings of the National Academy of Sciences of the United States of America · 2026

Deep dive in Tessa (opens in a new tab)Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 38 candidate papers

Selected

Nature's antivenom: Combinations of conserved rattlesnake serum metalloproteinase inhibitors block the lethal action of viper venoms.

Proceedings of the National Academy of Sciences of the United States of America · 2026 · PubMed, Europe PMC, Crossref

Tessa (opens in a new tab)Source (opens in a new tab)

And 32 more candidates considered.